SIRAKOSS provides bone grafting solutions to surgeons.
Our products enable the delivery of reliable bone healing in all patients. Our first formulation, Osteo3, is a unique, proprietary nanosynthetic bone graft substitute composed of novel inorganic granules. It provides significantly better healing in challenging models, supporting its potential for reliably achieving rapid patient recovery. SIRAKOSS has a unique focus on developing strong clinical data in support of product efficacy.
Company’s Keywords:
bone graft substitutes, orthopedics, trauma, spine, medical devices
<3
<
<2010